Stability of amphotericin b in an extemporaneously prepared i.v. fat emulsion

American Journal of Health-System Pharmacy

Volumn 53, Issue 22, 1996, Pages 2724-2727

  Lopez, Rosa M ^a,d   Ayestaran, Ana ^e   Pou, Leonor ^a   Montoro, Jose B ^b   Hernandez, Manuel ^c   Caragol, Isabel ^d  

^a Biochem Nephrology Urol B   (Spain)

^b Pharmacy Service

^c Biochemistry Service   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e NONE

Author keywords

Additives; Amphotericin B; Antifungals; Compounding; Concentration; Containers; Fat emulsions; Glass; Incompatibilities; Injections; Particle size distribution; Photodecomposition; Stability; Storage; Temperature

Indexed keywords

AMPHOTERICIN B; FUNGIZONA; INTRALIPID; LIPID EMULSION; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG MIXTURE; DRUG STABILITY; DRUG STORAGE; INTRAVENOUS DRUG ADMINISTRATION; LIGHT EXPOSURE; PRIORITY JOURNAL;

EID: 0029855683     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.22.2724     Document Type: Article

References (11)

1. Cipolle RJ, Solomkin JS. Amphotericin B. In: Taylor WJ, Caviness MH, eds. A textbook for the clinical application of therapeutic drug monitoring. Irving, TX: Abbott Laboratories; 1986:321-8.
2. Brajtburg J, Powderly WG, Kobayashi GS et al. Amphotericin B delivery systems. Antimicrob Agents Chemother. 1990; 34:381-4.
3. Chavenet PY, Garry I, Charlier N et al. Trial of glucose versus fat emulsion in preparation of amphotericin for use in HIV infected patients with candidiasis. BMJ. 1992; 305:921-5.
4. Janknegt R, Marie S, Bakker-Woundenberg IAJM et al. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet. 1992; 2:279-91.
5. Chavanet P, Charlier N, Brenet A et al. Emulsion de l'amphotericine B dans l'Intralipid 20%: efficacité in vitro et in vivo. Pathol Biol. 1992; 40:507-12.
6. Caillot F, López J, Bonnin A et al. Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidemia in neutropenic patients. J Antimicrob Chemother. 1993; 31:161-9.
7. Gates C, Pinney RJ. Amphotericin B and its delivery by liposomal and lipid formulations. J Clin Pharm Ther. 1993; 18:147-53.
8. Mitrano FP, Outman WR, Baptista RJ et al. Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4 °C for 35 days. Am J Hosp Pharm. 1991; 48:2635-7.
9. Kintzel PE, Kennedy PE. Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line. Am J Hosp Pharm. 1991; 48:283-5.
10. López RM, Pou L, Pascual C. Determination of amphotericin B in human serum by liquid chromatography. J Chromatogr B Biomed Appl. 1995; 674:298-300.
11. Sabin P, Monterde J, Cardona D et al. Incompatibilidad entre medicamentos y mezclas de nutrición parenteral. Estudio preliminar. Farm Clín. 1985; 2:162-70.